Open AccessComparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
Author(s) -
Sumit Randhir Singh,
Niroj Kumar Sahoo,
Nallamasa Rohit Goud,
Jay Chhablani
Publication year - 2019
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_638_18
Subject(s) - medicine , bevacizumab , visual acuity , aflibercept , ophthalmology , pro re nata , macular degeneration , retrospective cohort study , optometry , ranibizumab , surgery , chemotherapy
To report the visual and anatomical outcomes of intravitreal ziv-aflibercept (IVZ) and bevacizumab (BVZ) monotherapy in treatment-naive polypoidal choroidal vasculopathy (PCV).